Human Milk Oligosaccharides (HMO) Market Set for Explosive Growth with 21.75% CAGR by 2028

Human Milk Oligosaccharides (HMO) Market Set for Explosive Growth with 21.75% CAGR by 2028

MarkNtel Advisors recently published a detailed industry analysis of the Global Human Milk Oligosaccharides (HMO) Market. The report covers growth trends, geographical marketing strategies, challenges, opportunities, and drivers influencing the market.

Global Human Milk Oligosaccharides (HMO), Share, and Trends Analysis Report – Industry Overview and Forecast to 2028

The Human Milk Oligosaccharides (HMO) Market is projected to grow at a CAGR of around 21.75% during the forecast period, i.e., 2023-28.

Key Findings in Global Human Milk Oligosaccharides (HMO) Market:

• Historical Analysis: 2018 –2021
• Base Year: 2022
• Forecast Period: 2023-2028

Leading Market Players- Biosynth Carbosynth, Chr. Hansen Holding A/S, Dextra Laboratories Ltd., DuPont Nutrition & Biosciences, Elicityl S.A., Glycosyn, Inbiose NV, Medolac Laboratories, Nestle Health Science, ROYAL DSM, BASF SE, Abbott Laboratories, GNUBIOTICS Sciences S.A., Dextra Laboratories, Others

Key Highlights of the Report

• Market Dimensions And Projections
• Pricing Evaluation,
• Recent Strategic Moves by Companies,
• Primary Stakeholders,
• Analysis of Import and Export Trends,
• Competitive Landscape Assessment,
• Emerging Opportunities,
• Market Trends and Indicators

What are the major Driver the Global Human Milk Oligosaccharides (HMO) industry?

Increasing awareness of the Health Benefits of HMOs and the Rising Demand for Improved Infant Nutrition - There is a growing awareness of the crucial role of nutrition in early childhood development & long-term health outcomes. Since HMOs are naturally occurring components of breast milk, they have been linked to various health benefits, like a healthy gut microbiome, enhanced immunity, and protection against pathogens. This increased focus on infant health & nutrition is fueling the demand for HMOs in infant formula & baby food products worldwide. Numerous studies have cited the potential health benefits of HMOs for infants and created much evidence that supports the positive impact of HMOs on gut health, immune development, and overall well-being, which, in turn, has increased awareness & acceptance of HMOs among healthcare professionals, parents, & consumers. Hence, these factors are expected to drive the Global Human Milk Oligosaccharides (HMO) Market during 2023-28.

Download now and gain valuable insights to inform your business strategy, drive growth, and stay ahead of the competition - Download Free PDF Sample- https://www.marknteladvisors.com/query/request-sample/hmo-market.html

What segments define the Global Human Milk Oligosaccharides (HMO) Market from 2023 to 2028? How do these segments contribute to market dynamics and growth?

By Type

• 2’FL- Market Size & Forecast 2018-2028, (USD Million)
• 3’FL- Market Size & Forecast 2018-2028, (USD Million)
• 3’SL- Market Size & Forecast 2018-2028, (USD Million)
• 6’SL- Market Size & Forecast 2018-2028, (USD Million)

According to report, Of them all, 2'-FL dominates the Global Human Milk Oligosaccharides (HMO) Market, mainly on account of its structural similarity to & abundance in human breast milk, owing to which it is extensively studied & successfully produced on a commercial scale globally.

By Application

• Infant formula- Market Size & Forecast 2018-2028, (USD Million)
• Functional food & beverage- Market Size & Forecast 2018-2028, (USD Million)
• Food supplements- Market Size & Forecast 2018-2028, (USD Million)
• Others-Market Size & Forecast 2018-2028, (USD Million)

According to report, Here, infant formula is the leading application for HMOs and is used extensively as a substitute for breast milk across various regions where breastfeeding rates are less.

By Concentration

• Neutral- Market Size & Forecast 2018-2028, (USD Million)
• Acidic- Market Size & Forecast 2018-2028, (USD Million)
• Others-- Market Size & Forecast 2018-2028, (USD Million)

By Distribution Channel

• Hypermarkets & Supermarkets- Market Size & Forecast 2018-2028, (USD Million)
• Drug store or pharmacy- Market Size & Forecast 2018-2028, (USD Million)
• Mass merchandiser- Market Size & Forecast 2018-2028, (USD Million)
• Departmental Stores- Market Size & Forecast 2018-2028, (USD Million)
• Mono-brand Store-Market Size & Forecast 2018-2028, (USD Million)
• Specialty stores-Market Size & Forecast 2018-2028, (USD Million)

Explore the Complete Global Human Milk Oligosaccharides (HMO) Market Analysis Report – https://www.marknteladvisors.com/research-library/hmo-market.html

Geographical Analysis: Global Human Milk Oligosaccharides (HMO) Market

 By Region

• North America
• Europe
• Asia-Pacific
• Rest of the World

The Global Human Milk Oligosaccharides (HMO) Industry Recent Development:

• On 18 November 2022, KYOWA HAKKO BIO CO. LTD., a subsidiary of Kirin Holdings Company, Limited, completed the HMO production facility at its Thai subsidiary, THAI KYOWA BIOTECHNOLOGIES CO., LTD.
• On 31 October 2022, FrieslandCampina got approval from Australia’s & New Zealand’s authorities for using its 2’-FL trademarked Aequival in infant milk formula, i.e., in line with expanding its HMO portfolio.

Key Questions Addressed in This Study

• What are the primary factors driving the growth of the Global Human Milk Oligosaccharides (HMO)?
• How is the Global Human Milk Oligosaccharides (HMO) expected to evolve over the next five years?
• What key insights can be drawn from current trends shaping the market?
• What is the current market size, and how is it forecasted to change in the coming years?
• What is the future outlook for the market in terms of technological innovation and geographic expansion?

For a Customized Analysis Report, Just Drop Your Inquiry Here – https://www.marknteladvisors.com/query/request-customization/hmo-market.html

Why MarkNtel Advisors?

MarkNtel Advisors is a leading research, consulting, And data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial And varied client base, including multinational corporations, financial institutions, governments, And individuals, among others.

Our specialization in niche industries informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing And forecasting, And trend analysis, among others, for 15 diverse industrial verticals.

More Research Studies Report:

-Biocomposites Market size was valued at around USD 36.9 billion in 2024 and is projected to reach USD 89 billion by 2028 with a CAGR of around 119.27%.

-Green Solvents Market size was valued at around USD 1.34 billion in 2024 And is projected to reach USD 1.87 billion by 2028 with a CAGR of around 5.7%.

For Media Inquiries, Please Contact:

Email: sales@marknteladvisors.com

Trending Blogs : www.marknteladvisors.com/blogs

Export-import Data : https://www.marknteladvisors.com/export-import-data